 Although ephedra showed some effectiveness for short-term weight loss, it was linked to raising blood pressure and increasing the risk of heart problems and stroke.In March 2014, Chattem sold Dexatrim to NVE Pharmaceuticals.Currently, no over-the-counter weight-loss supplements have met criteria for recommended use by physicians.